Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Splicing factor gene mutations in acute myeloid leukemia offer additive value if incorporated in current risk classification

Inge van der Werf, Anna Wojtuszkiewicz, Manja Meggendorfer, Stephan Hutter, Constance Baer, Martijn Heymans, Peter J. M. Valk, Wolfgang Kern, Claudia Haferlach, Jeroen J. W. M. Janssen, Gert J. Ossenkoppele, Jacqueline Cloos, Torsten Haferlach

Blood Adv (2021) 5 (17): 3254–3265.

https://doi.org/10.1182/bloodadvances.2021004556

Published: 2021

Includes: Supplemental data

Journal Articles

Genomic and clinical characterization of early T-cell precursor lymphoblastic lymphoma

Xinjie Xu, Christian N. Paxton, Robert J. Hayashi, Kimberly P. Dunsmore, Stuart S. Winter, Stephen P. Hunger, Naomi J. Winick, William L. Carroll, Mignon L. Loh, Meenakshi Devidas, Thomas G. Gross, Catherine M. Bollard, Sherrie L. Perkins, Rodney R. Miles

Blood Adv (2021) 5 (14): 2890–2900.

https://doi.org/10.1182/bloodadvances.2021004334

Published: 2021

Includes: Supplemental data

Journal Articles

Khurana A, Novo M, Nowakowski GS, et al. Clinical manifestations of, diagnostic approach to, and treatment of neurolymphomatosis in the rituximab era. Blood Adv. 2021;5(5):1379-1387.

Blood Adv (2021) 5 (7): 2053.

https://doi.org/10.1182/bloodadvances.2021004700

Published: 2021

Journal Articles

ETV6-FLT3– positive myeloid/lymphoid neoplasm with eosinophilia presenting in an infant: an entity distinct from JMML

Barbara Spitzer, Filemon S. Dela Cruz, Glorymar D. Ibanez Sanchez, Yanming Zhang, Wenbin Xiao, Ryma Benayed, Alina Markova, M. Irene Rodriguez-Sanchez, Nancy Bouvier, Mikhail Roshal, Andrew L. Kung, Neerav Shukla

Blood Adv (2021) 5 (7): 1899–1902.

https://doi.org/10.1182/bloodadvances.2020003699

Published: 2021

Journal Articles

A prognostic score including mutation profile and clinical features for patients with CMML undergoing stem cell transplantation

Blood Adv (2021) 5 (6): 1760–1769.

https://doi.org/10.1182/bloodadvances.2020003600

Published: 2021

Includes: Supplemental data

Journal Articles

Outcomes of older patients with follicular lymphoma using individual data from 5922 patients in 18 randomized controlled trials

Blood Adv (2021) 5 (6): 1737–1745.

https://doi.org/10.1182/bloodadvances.2020002724

Published: 2021

Journal Articles

Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis

Blood Adv (2021) 5 (5): 1452–1462.

https://doi.org/10.1182/bloodadvances.2020003614

Published: 2021

Includes: Supplemental data

Journal Articles

Clinical manifestations of, diagnostic approach to, and treatment of neurolymphomatosis in the rituximab era

Arushi Khurana, Mattia Novo, Grzegorz S. Nowakowski, Kay M. Ristow, Robert J. Spinner, Christopher H. Hunt, Rebecca L. King, Daniel H. Lachance, Thomas M. Habermann, Ivana N. Micallef, Patrick B. Johnston

Blood Adv (2021) 5 (5): 1379–1387.

https://doi.org/10.1182/bloodadvances.2020003666

Published: 2021

Includes: Supplemental data

Journal Articles

Nationwide survey of systemic chronic active EBV infection in Japan in accordance with the new WHO classification

Ichiro Yonese, Chizuko Sakashita, Ken-Ichi Imadome, Tohru Kobayashi, Masahide Yamamoto, Akihisa Sawada, Yoshinori Ito, Noriko Fukuhara, Asao Hirose, Yusuke Takeda, Masanori Makita, Tomoyuki Endo, Shun-ichi Kimura, Masataka Ishimura, Osamu Miura, Shouichi Ohga, Hiroshi Kimura, Shigeyoshi Fujiwara, Ayako Arai

Blood Adv (2020) 4 (13): 2918–2926.

https://doi.org/10.1182/bloodadvances.2020001451

Published: 2020

Includes: Supplemental data

Journal Articles

Integrating clinical features with genetic factors enhances survival prediction for adults with acute myeloid leukemia

Douglas R. A. Silveira, Lynn Quek, Itamar S. Santos, Anna Corby, Juan L. Coelho-Silva, Diego A. Pereira-Martins, Grant Vallance, Benjamin Brown, Luciana Nardinelli, Wellington F. Silva, Elvira D. R. P. Velloso, Antonio R. Lucena-Araujo, Fabiola Traina, Andy Peniket, Paresh Vyas, Eduardo M. Rego, Israel Bendit, Vanderson Rocha

Blood Adv (2020) 4 (10): 2339–2350.

https://doi.org/10.1182/bloodadvances.2019001419

Published: 2020

Includes: Supplemental data

Journal Articles

Clinical diagnostics and treatment strategies for Philadelphia chromosome–like acute lymphoblastic leukemia

Richard C. Harvey, Sarah K. Tasian

Blood Adv (2020) 4 (1): 218–228.

https://doi.org/10.1182/bloodadvances.2019000163

Published: 2020

Journal Articles

DNA methylation identifies genetically and prognostically distinct subtypes of myelodysplastic syndromes

Brian Reilly, Tiffany N. Tanaka, Dinh Diep, Huwate Yeerna, Pablo Tamayo, Kun Zhang, Rafael Bejar

Blood Adv (2019) 3 (19): 2845–2858.

https://doi.org/10.1182/bloodadvances.2019000192

Published: 2019

Includes: Supplemental data

Journal Articles

Allogeneic reactivity–mediated endothelial cell complications after HSCT: a plea for consensual definitions

Simona Pagliuca, David Michonneau, Flore Sicre de Fontbrune, Aurélien Sutra del Galy, Aliénor Xhaard, Marie Robin, Régis Peffault de Latour, Gérard Socie

Blood Adv (2019) 3 (15): 2424–2435.

https://doi.org/10.1182/bloodadvances.2019000143

Published: 2019

Journal Articles

Distinct clinical and biological implications of CUX1 in myeloid neoplasms

Mai Aly, Zubaidah M. Ramdzan, Yasunobu Nagata, Suresh K. Balasubramanian, Naoko Hosono, Hideki Makishima, Valeria Visconte, Teodora Kuzmanovic, Vera Adema, Aziz Nazha, Bartlomiej P. Przychodzen, Cassandra M. Kerr, Mikkael A. Sekeres, Mohamed E. Abazeed, Alain Nepveu, Jaroslaw P. Maciejewski

Blood Adv (2019) 3 (14): 2164–2178.

https://doi.org/10.1182/bloodadvances.2018028423

Published: 2019

Includes: Supplemental data

Journal Articles

Cell-lineage level–targeted sequencing to identify acute myeloid leukemia with myelodysplasia-related changes

Kazuaki Yokoyama, Eigo Shimizu, Nozomi Yokoyama, Sousuke Nakamura, Rika Kasajima, Miho Ogawa, Tomomi Takei, Mika Ito, Asako Kobayashi, Rui Yamaguchi, Seiya Imoto, Satoru Miyano, Arinobu Tojo

Blood Adv (2018) 2 (19): 2513–2521.

https://doi.org/10.1182/bloodadvances.2017010744

Published: 2018

Includes: Supplemental data

Journal Articles

The remarkable diversity of thrombotic thrombocytopenic purpura: a perspective

James N. George

Blood Adv (2018) 2 (12): 1510–1516.

https://doi.org/10.1182/bloodadvances.2018018432

Published: 2018

Journal Articles

Epidemiology, clinical features, and outcome of HTLV-1–related ATLL in an area of prevalence in the United States

Luis Malpica, Agustin Pimentel, Isildinha M. Reis, Eduardo Gotuzzo, Lazaros Lekakis, Krishna Komanduri, Thomas Harrington, Glen N. Barber, Juan C. Ramos

Blood Adv (2018) 2 (6): 607–620.

https://doi.org/10.1182/bloodadvances.2017011106

Published: 2018

Includes: Supplemental data

Journal Articles

Next-generation sequencing of idiopathic multicentric and unicentric Castleman disease and follicular dendritic cell sarcomas

Alexandra Nagy, Aparna Bhaduri, Nahid Shahmarvand, Jahanbanoo Shahryari, James L. Zehnder, Roger A. Warnke, Tariq Mughal, Siraj Ali, Robert S. Ohgami

Blood Adv (2018) 2 (5): 481–491.

https://doi.org/10.1182/bloodadvances.2017009654

Published: 2018

Includes: Supplemental data

Journal Articles

Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015

Evaren E. Page, Johanna A. Kremer Hovinga, Deirdra R. Terrell, Sara K. Vesely, James N. George

Blood Adv (2017) 1 (10): 590–600.

https://doi.org/10.1182/bloodadvances.2017005124

Published: 2017

Journal Articles

Somatic mutations in children with GATA2 -associated myelodysplastic syndrome who lack other features of GATA2 deficiency

Kevin E. Fisher, Amy P. Hsu, Christopher L. Williams, Hadi Sayeed, Brian Y. Merritt, M. Tarek Elghetany, Steven M. Holland, Alison A. Bertuch, Maria Monica Gramatges

Blood Adv (2017) 1 (7): 443–448.

https://doi.org/10.1182/bloodadvances.2016002311

Published: 2017

Includes: Supplemental data

NARROW

Splicing factor gene mutations in acute myeloid leukemia offer additive value if incorporated in current risk classification

Genomic and clinical characterization of early T-cell precursor lymphoblastic lymphoma

Khurana A, Novo M, Nowakowski GS, et al. Clinical manifestations of, diagnostic approach to, and treatment of neurolymphomatosis in the rituximab era. Blood Adv. 2021;5(5):1379-1387.

ETV6-FLT3– positive myeloid/lymphoid neoplasm with eosinophilia presenting in an infant: an entity distinct from JMML

A prognostic score including mutation profile and clinical features for patients with CMML undergoing stem cell transplantation

Outcomes of older patients with follicular lymphoma using individual data from 5922 patients in 18 randomized controlled trials

Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis

Clinical manifestations of, diagnostic approach to, and treatment of neurolymphomatosis in the rituximab era

Nationwide survey of systemic chronic active EBV infection in Japan in accordance with the new WHO classification

Integrating clinical features with genetic factors enhances survival prediction for adults with acute myeloid leukemia

Clinical diagnostics and treatment strategies for Philadelphia chromosome–like acute lymphoblastic leukemia

DNA methylation identifies genetically and prognostically distinct subtypes of myelodysplastic syndromes

Allogeneic reactivity–mediated endothelial cell complications after HSCT: a plea for consensual definitions

Distinct clinical and biological implications of CUX1 in myeloid neoplasms

Cell-lineage level–targeted sequencing to identify acute myeloid leukemia with myelodysplasia-related changes

The remarkable diversity of thrombotic thrombocytopenic purpura: a perspective

Epidemiology, clinical features, and outcome of HTLV-1–related ATLL in an area of prevalence in the United States

Next-generation sequencing of idiopathic multicentric and unicentric Castleman disease and follicular dendritic cell sarcomas

Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015

Somatic mutations in children with GATA2 -associated myelodysplastic syndrome who lack other features of GATA2 deficiency

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only